This note highlights a shift in the evidence base for dementia interventions, underscoring the need for cautious interpretation of treatment benefits and risks. For mental health professionals, the finding that amyloid-clearing therapies may offer little patient-level improvement while elevating brain risk informs discussions about treatment expectations, monitoring, and shared decision-making with clients and families. It also reinforces the importance of considering adverse effects and the overall risk–benefit balance when evaluating pharmacological options within neurodegenerative care.
Article Title: Alzheimer’s drugs may not work and could raise brain risks
Link to Science Daily Mind-Brain News: https://nolinkpreview.com/www.sciencedaily.com/releases/2026/05/260502233915.htm
#alzheimers #amyloid #neurodegeneration #brainhealth #clinicaltrials #treatmentrisks #drugtherapy #neuropsychology #mindbrainnews #shareddecisionmaking
